NYSE: ENFN
Enfusion Inc Stock Ownership - Who owns Enfusion?

Insider buying vs selling

Have Enfusion Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Oleg MovchanChief Executive Officer2025-03-0611,452$11.39
$130.47kSell
Neal PawarChief Operating Officer2025-03-0514,560$11.38
$165.62kSell
Valeria GutowskiChief Accounting Officer2025-03-05542$11.38
$6.17kSell
Bradley HerringChief Financial Officer2025-03-054,645$11.38
$52.84kSell
Matthew CampobassoGeneral Counsel2025-03-051,695$11.38
$19.28kSell
Bronwen BastoneChief People Officer2025-03-053,126$11.38
$35.56kSell
Valeria GutowskiChief Accounting Officer2025-03-041,233$11.37
$14.01kSell
Valeria GutowskiChief Accounting Officer2025-03-03219$11.48
$2.51kSell
Neal PawarChief Operating Officer2025-03-032,769$11.48
$31.79kSell
Oleg MovchanChief Executive Officer2025-03-032,790$11.48
$32.03kSell

1 of 4

ENFN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENFN insiders and whales buy or sell their stock.

ENFN Shareholders

What type of owners hold Enfusion Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ftv Management Company LP25.15%32,440,463$354.25MInstitution
Bradford E. Bernstein25.15%32,440,463$354.25MInsider
Iconiq Capital LLC10.88%14,039,594$153.31MInstitution
Roy Luo6.98%9,009,594$98.38MInsider
Iconiq Strategic Partners V LP6.98%9,009,594$98.38MInsider
Isp Vb Ef LP6.01%7,748,000$84.61MInsider
Brown Capital Management LLC5.54%7,147,530$78.05MInstitution
Hillhouse Investment Management Ltd3.86%4,975,183$54.33MInsider
Hhlr Advisors Ltd3.86%4,975,183$54.33MInstitution
Oleg Movchan3.24%4,185,483$45.71MInsider

1 of 3

ENFN vs App Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENFN55.41%44.59%Net SellingNet Selling
LSPD58.10%0.00%
IBTA51.28%48.72%Net SellingNet Selling
PD68.16%31.84%Net SellingNet Selling
JAMF24.82%75.18%Net SellingNet Selling

Enfusion Stock Ownership FAQ

Who owns Enfusion?

Enfusion (NYSE: ENFN) is owned by 70.66% institutional shareholders, 56.87% Enfusion insiders, and 0.00% retail investors. Bradford E. Bernstein is the largest individual Enfusion shareholder, owning 32.44M shares representing 25.15% of the company. Bradford E. Bernstein's Enfusion shares are currently valued at $350.36M.

If you're new to stock investing, here's how to buy Enfusion stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.